| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |